Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine

BMC Health Services Research
http://www.biomedcentral.com/bmchealthservres/content
(Accessed 11 Apr 2020)

 

Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine
The phased withdrawal of oral polio vaccine (OPV) and the introduction of inactivated poliovirus vaccine (IPV) is central to the polio ‘end-game’ strategy.
Authors: Ignacio Olivera, Carlos Grau, Hugo Dibarboure, Juan Pablo Torres, Gustavo Mieres, Luis Lazarov, Fabián P. Alvarez and Juan Guillermo López Yescas
Citation: BMC Health Services Research 2020 20:295
Content type: Research article
Published on: 9 April 2020